PHARMACOGENETICS
PHARMACOLOGICAL COMPATIBILITY
PHARMACOLOGIC COMPATIBILITY
HOW CAN THIS HELP ME?
Pharmacogenetics is the starting point to having medicine personalized based on your health map. Our dna reveals that we are each different which is why our organism processes drugs in different ways. You will understand why your body reacts in a certain way to divers drugs when you have your health map. It will serve as an valuable guide to allow your doctor to prescribe the best drug treatment with the most adequate dosage for each of your illnesses. You will reduce your recuperation time and increase safety by minimizing the possibility of adverse or undesired secondary effects.
- Abacavir hypersensitivity
- Acenocoumarol and Phenprocoumon Metabolization
- Acenocoumarol and Phenprocoumon Response
- Acetaldehyde toxicity
- Adjuvant chemotherapy in primary breast cancer. Trastuzumab (Herceptin)
- Amifampridine metabolization
- Amitriptyline Metabolization
- Antidepressants and Blood-Brain Barrier
- Antidiabetics Response (sulphonylureas)
- Antipsychotics and weight gain (amisulpride, aripiprazole, clozapine, olanzapine, haloperidol, quetiapine, risperidone, ziprasidone, palperidone)
- Arformoterol metabolization
- Aspirin and asthma
- Aspirin and cardiovascular risk
- Aspirin and colorectal cancer
- Aspirin resistance and prothrombotic effect
- Asthma and inhaled corticosteroids
- Atazanavir metabolization
- Atenolol Response
- Atomoxetine metabolization
- Bevacizumab response in colorectal cancer
- Bisoprolol Response
- Bleomycin and testicular (germ cell ) cancer
- Brivaracetam metabolization
- Bupropion (Zyban)
- Bupropion and Side Effects
- Cabozantinib response and medullary thyroid cancer
- Caffeine metabolism
- Carbamazepine Metabolization
- Carbamazepine tolerance and side effects
- Carvedilol Metabolization
- Celecoxib Metabolization
- Cisplatine response
- Citalopram Metabolization
- Clozapine Metabolization
- Codeine Metabolization
- COPD treatment. (Combined treatment Corticosteroids + B2 Agonists)
- Cyclophosphamide Toxicity (and other chemotherapeutic agents)
- Diazepam Metabolization
- Disulfiram (Antabuse) and alcoholism
- Docetaxel and leukopenia in cancer treatment
- Donepezil Metabolization (applicable to Galantamine)
- Duloxetine Response
- Eliglustat metabolization
- Erythromycin Sulfisoxazole and Hemolysis
- Escitalopram Metabolization
- Esomeprazole Metabolization
- Fesoterodine metabolization
- Flecainide metabolization
- Floxacillin toxicity
- Fluorouracil toxicity
- Fluoxetine Metabolization
- Fluoxetine, Citalopram and Escitalopram Response
- Fluvoxamine Metabolization
- Gefitinib and lung cancer
- Gemcitabine Response in breast cancer
- Gemcitabine Response in mesothelioma
- Gemcitabine Response in non-small cell lung cancer
- Gemcitabine Response in pancreatic cancer
- Gemcitabine Toxicity in pancreatic cancer
- Glimepiride, Glyburide and Glicazide Metabolization
- Glipizide Metabolization
- Gonadotropins and other ovulation-stimulating drugs
- Hepatitis C response to treatment
- High blood pressure treatment with common drugs
- Hypersensitivity to Vaccination
- Illoperidone and prolongation of the QTc interval
- Illoperidone Metabolization
- Illoperidone response
- Interaction Atazanavir and antifungals
- Irinotecan and colorectal cancer
- Ivacaftor and cystic fibrosis
- Lorazepam metabolization
- LUM/IVA and cystic fibrosis
- Metabolization of Aripiprazole
- Metabolization of Brexpiprazole
- Metabolization of Carisoprodol
- Metabolization of Clobazam
- Metabolization of Clopidogrel
- Metabolization of Cyclosporine
- Metabolization of Desipramine
- Metabolization of Fentanyl
- Metabolization of Haloperidol
- Metabolization of Lansoprazole
- Metabolization of Mercaptopurine
- Metabolization of Nortriptyline
- Metabolization of Palonosetron
- Metabolization of Perphenazine
- Metabolization of Pimozide
- Metabolization of Prasugrel
- Metabolization of Quetiapine
- Metabolization of Simvastatin
- Metabolization of Zuclopenthixol
- Metformin response
- Methadone. Heroin addiction
- Metoprolol Metabolization
- Mipomersen and familial hypercholesterolemia
- Mirtazapine Response
- Montelukast metabolization
- Montelukast response
- Naltrexone and alcoholism
- Nelfinavir Metabolization (HIV)
- Nelfinavir Response (HIV)
- Olanzapine and schizophrenia
- Olanzapine and weight gain
- Omeprazole Metabolization
- Paclitaxel (chemotherapy) and development of hematotoxicity
- Paclitaxel (chemotherapy) and development of neuropathies
- Paclitaxel Metabolization (chemotherapy) and toxicity
- Paclitaxel Response (chemotherapy)
- Pantoprazole Metabolization
- Paroxetin Metabolization
- Phenytoin Metabolization
- Phenytoin sensitivity
- Post-operative nausea and vomiting
- Propranolol Metabolization
- Rabeprazole Metabolization
- Response to Acetylcholinesterase Inhibitors (ChEIs) in Alzheimer’s disease (galantamine, donepezil, rivastigmine)
- Response to Chlorthalidone
- Response to Cyclophosphamide (and other chemotherapeutic agents) in breast cancer
- Response to Furosemide and Torasemide
- Response to Hydrochlorothiazide
- Response to Imatinib
- Response to Lithium in Bipolar Disorder
- Response to Methylphenidate
- Response to Olaparib in breast and ovarian cancer
- Response to Valproic Acid and adverse effects
- Response to β-blockers (Metoprolol, Carvedilol, Propranolol)
- Risperidone and weight gain
- Risperidone Metabolization
- Risperidone Response
- Rosiglitazone response in diabetics
- Selection of Prasugrel, Ticagrelor and Clopidogrel in Cardiovascular Diseases
- Sertraline Metabolization
- Sexual dysfunction in response to SSRIs
- Sildenafil effect (Viagra ®)
- Statins and myopathy
- Sulfonylurea metabolism
- Tacrolimus Metabolization in Transplants
- Tamoxifen Metabolization in Breast Cancer (Prognosis)
- Thiopurine methyltransferase enzyme activity
- Ticagrelor Metabolization
- Tolbutamide Metabolization
- Tramadol Metabolization
- Venlafaxine Metabolization
- Venlafaxine Response
- Voriconazole and cell transporters
- Voriconazole Metabolization
- Warfarin Metabolization
- Warfarin Response
- Ziprasidone Response
After the assessment administered by the FDA, the pharmacogenetic section made unavailable to our users within the USA. As soon as it is feasible to offer pharmacogenetics information to our users within the USA, we’ll get in touch and share pharmacogenetics information at no additional cost.
